• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 453103 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416840232 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416840232 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Questcor Pharmaceuticals Bearish Moving Average Crossover Alert (QCOR)

Published on Tue, 03/05/2013 - 12:16
By Mallory Stone

Today, shares of Questcor Pharmaceuticals (NASDAQ:QCOR) have fallen below their 10-day MA of $31.81 on a volume of 791K shares. Swing traders may find an opportunity for a short position, as such a crossover often suggests lower prices in the near term.

Questcor Pharmaceuticals (NASDAQ:QCOR) has potential upside of 56.8% based on a current price of $31.51 and analysts' consensus price target of $49.40. The stock should find resistance at its 200-day moving average (MA) of $34.12, as well as support at its 50-day MA of $27.76.

Questcor Pharmaceuticals, Inc. develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. The Company's primary product is a natural source adrenocorticotropic hormone indicated for the treatment of acute exacerbations of multiple sclerosis, as well as a number of other conditions.

In the past 52 weeks, Questcor Pharmaceuticals share prices have been bracketed by a low of $14.52 and a high of $58.91 and are now at $31.51, 117% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.3% while the 50-day MA has advanced 0.9%.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Analyst Rating Flashback: Procter & Gamb...

A week ago, Canaccord Genuity downgraded Procter & Gamble from Buy to Hold. Procter & ...

Possible Bearish Inside Day Candle Patte...

Analysts have spotted a possible bearish inside day candle pattern in Dillard's (NYSE:D ...

Hudson City Bancorp had the Lowest Relat...

Analysis was conducted on the Thrifts & Mortgage Finance industry to measure relative p ...

Short-term Underperformance Detected in ...

Here are 5 stocks in the Specialty Chemicals industry ranked by performance. We compil ...

Analysis of Relative Performance in the ...

Below are five companies in the Specialized Finance industry that underperformed yester ...

Shares of Intel Underperformed its Peers...

Here are 5 stocks in the Semiconductors industry ranked by performance. We compiled th ...

Shares of Ultratech Underperformed its P...

Analysis was conducted on the Semiconductor Equipment industry to measure relative perf ...

Shares of CBL & Associates Properties Un...

Here are 5 stocks in the Retail REITs industry ranked by performance. We compiled the ...